Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “California”
Sponsor: Amgen
Cardiovascular Disease
United States, Australia, Canada
- Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Uterine Neoplasms · Uterine Cervical Neoplasms · Biliary Tract Neoplasms · Urologic Neoplasms
United States, Belgium, Germany, Italy, Japan +3 more
- Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic AreaRecruiting
Sponsor: Boston Scientific Corporation
Anastomotic Leaks · Hartmanns Stump Leakage
United States
- IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver CancerActive Not Recruiting
Sponsor: City of Hope Medical Center
Recurrent Hepatocellular Carcinoma · Refractory Liver Carcinoma · Stage IV Hepatocellular Carcinoma AJCC v8 · Stage IVA Hepatocellular Carcinoma AJCC v8
United States
Sponsor: Stanford University
Post Partum Hemorrhage · Cesarean Section Complications · Blood Loss
United States
Sponsor: Merck Sharp & Dohme LLC
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Kyowa Kirin, Inc.
T-cell NHL (PTCL or CTCL)
United States, Italy, Spain
Sponsor: Beijing Inno Medicine Co., Ltd.
Atherosclerosis · Coronary Artery Disease
United States, Australia, Canada, China
Sponsor: City of Hope Medical Center
Castration-Resistant Prostate Carcinoma · Metastatic Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8
United States
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisRecruiting
Sponsor: AbbVie
Ulcerative Colitis
United States, Belgium, Brazil, Canada, China +10 more
- A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus ErythematosusEnrolling By Invitation
Sponsor: UCB Biopharma SRL
Systemic Lupus Erythematosus
United States, Argentina, Belgium, Bulgaria, Canada +19 more
Sponsor: University of California, Los Angeles
Autism Spectrum Disorder (ASD)
United States
Sponsor: Amgen
Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +30 more
Sponsor: Eli Lilly and Company
Bipolar Disorder
United States, Argentina, Brazil, China, India +3 more
Sponsor: Stanford University
Depression - Major Depressive Disorder · Older Adults (65 Years and Older) · Behavioral Activation Treatment · Virtual Reality Therapy
United States
Sponsor: Johns Hopkins University
Chronic Obstructive Pulmonary Disease Severe · Chronic Bronchitis
United States
Sponsor: Hoffmann-La Roche
Obesity or Overweight
United States
- Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Polymyalgia Rheumatica
United States, Argentina, Australia, Belgium, Brazil +17 more
- Virtual Reality (VR) Audiovisual Distraction to Reduce Pain and Anxiety for Prone Pain ProceduresNot Yet Recruiting
Sponsor: University of California, Davis
Procedural Pain · Procedural Anxiety
United States
Sponsor: Eli Lilly and Company
Atherosclerosis · Cardiovascular Diseases · Lipoprotein(a)
United States, Australia, Czechia, Hungary, Netherlands +2 more
Sponsor: Eli Lilly and Company
Breast Neoplasms · Colorectal Neoplasms · Prostate Neoplasm · Endometrial Neoplasms
United States, Canada, China, France, Germany +2 more
- A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )Recruiting
Sponsor: Eli Lilly and Company
Lymphoma, Non-Hodgkin · B-cell Lymphoma · Lymphoma, Large B-Cell, Diffuse · Lymphoma, Follicular
United States, Australia, Canada, Denmark, France +7 more
- Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This MedicineActive Not Recruiting
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Australia, Belgium, Bulgaria, Canada +17 more
Sponsor: Laguna Biotherapeutics, Inc.
Acute Leukemia · Myelodysplastic Syndrome
United States
- A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)Completed
Sponsor: EMD Serono Research & Development Institute, Inc.
Non-small Cell Lung Cancer
United States, Belgium, China, France, Germany +12 more